2-((4-(2-amino-4-methoxypyrimidin-5-yl)-1H-imidazol-1-yl)methoxy)ethan-1-ol

ID: ALA3596788

Chembl Id: CHEMBL3596788

PubChem CID: 91824158

Max Phase: Preclinical

Molecular Formula: C11H15N5O3

Molecular Weight: 265.27

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1nc(N)ncc1-c1cn(COCCO)cn1

Standard InChI:  InChI=1S/C11H15N5O3/c1-18-10-8(4-13-11(12)15-10)9-5-16(6-14-9)7-19-3-2-17/h4-6,17H,2-3,7H2,1H3,(H2,12,13,15)

Standard InChI Key:  CVSSXRUFNBCRPB-UHFFFAOYSA-N

Associated Targets(Human)

HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Huh-7 (12904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ebolavirus (617 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rift Valley fever virus (132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lassa virus (234 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dengue virus (413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 265.27Molecular Weight (Monoisotopic): 265.1175AlogP: -0.10#Rotatable Bonds: 6
Polar Surface Area: 108.31Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.37CX LogP: -0.15CX LogD: -0.16
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.70Np Likeness Score: -0.64

References

1. Peters HL, Jochmans D, de Wilde AH, Posthuma CC, Snijder EJ, Neyts J, Seley-Radtke KL..  (2015)  Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity.,  25  (15): [PMID:26048809] [10.1016/j.bmcl.2015.05.039]
2. Yates MK, Raje MR, Chatterjee P, Spiropoulou CF, Bavari S, Flint M, Soloveva V, Seley-Radtke KL..  (2017)  Flex-nucleoside analogues - Novel therapeutics against filoviruses.,  27  (12): [PMID:28465098] [10.1016/j.bmcl.2017.04.069]
3. Nascimento IJDS, Santos-Júnior PFDS, Aquino TM, Araújo-Júnior JX, Silva-Júnior EFD..  (2021)  Insights on Dengue and Zika NS5 RNA-dependent RNA polymerase (RdRp) inhibitors.,  224  [PMID:34274831] [10.1016/j.ejmech.2021.113698]

Source